Primary Myelofibrosis with Mesenteric Extramedullary Haematopoiesis

Primary Myelofibrosis with Mesenteric Extramedullary Haematopoiesis

Primary myelofibrosis or chronic idiopathic myelofibrosis is a myeloproliferative neoplasm characterized by proliferation of abnormal haematopoietic stem cells in bone marrow resulting in replacement of marrow with fibrotic scar tissue. Extramedullary Haematopoiesis (EMH) as a compensatory phenome...

Full description

Bibliographic Details
Main Authors:	Saurabh Kumar, Shaloo Shaloo, Juhi Chawla, Subha Ashok, Shalini Thapar Laroia
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2018-12-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	megakaryocytes myeloproliferative neoplasm osteosclerosis
Online Access:	https://jcdr.net/articles/PDF/12321/37276_CE[Ra]_F(P)_PF1(A_SHU)%20_PFA(SHU)_PB(A_SHU)_PN(P).pdf

Similar Items

Inhibition of Osteoblast Differentiation by JAK2V617F Megakaryocytes Derived From Male Mice With Primary Myelofibrosis
by: Aikaterini Karagianni, et al.
Published: (2022-07-01)

Sclerosing Extramedullary Haematopoietic Tumour Presenting as Bilateral Gluteal Abscess in a Patient with Chronic Myelogenous Leukaemia
by: KS Sunil Kumar, et al.
Published: (2018-12-01)

Shared and Distinctive Ultrastructural Abnormalities Expressed by Megakaryocytes in Bone Marrow and Spleen From Patients With Myelofibrosis
by: Maria Zingariello, et al.
Published: (2020-11-01)

Transcription factor 3 is dysregulated in megakaryocytes in myelofibrosis
by: Ryan J Collinson, et al.
Published: (2024-12-01)

A Novel Morphological Parameter Predicting Fibrotic Evolution in Myeloproliferative Neoplasms: New Evidence and Molecular Insights
by: Vincenzo Fiorentino, et al.
Published: (2022-07-01)

Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants
by: Elena Masselli, et al.
Published: (2020-09-01)

Mutated JAK2 signal transduction in human induced pluripotent stem cell (iPSC)-derived megakaryocytes
by: Jaturawat Pawinwongchai, et al.
Published: (2022-07-01)

Primary myelofibrosis with extramedullary hematopoiesis – A case report with a review of literature
by: Gaurav Mehta, et al.
Published: (2023-01-01)

Megakaryocytic morphology in Janus kinase 2 V617F positive myeloproliferative neoplasm
by: Shuchi Ghai, et al.
Published: (2017-01-01)

Focus on Osteosclerotic Progression in Primary Myelofibrosis
by: Mariarita Spampinato, et al.
Published: (2021-01-01)

Pulmonary extramedullary hematopoiesis involving the pulmonary artery
by: Varun Monga, et al.
Published: (2015-03-01)

Primary Myelofibrosis in the Prefibrotic Stage Presenting as Portal, Splenic, and Superior Mesenteric Vein Thrombosis: A Case Report and Review of the Literature
by: Emanuel Dias, et al.
Published: (2021-05-01)

Primary myelofibrosis: spectrum of imaging features and disease-related complications
by: Sheng Fei Oon, et al.
Published: (2019-08-01)

Frequency of JAK2 and MPL Mutation in BCR/ABL Negative Myelofibrosis in KPK
by: Ayesha Gul, et al.
Published: (2022-06-01)

Acute Myeloid Leukemia with Isolated Trisomy 19 Associated with Diffuse Myelofibrosis and Osteosclerosis
by: Adam Stelling, et al.
Published: (2015-12-01)

New Markers of Disease Progression in Myelofibrosis
by: Rita Campanelli, et al.
Published: (2021-10-01)

Extramedullary Hematopoiesis of the Liver and Spleen
by: Diana Cenariu, et al.
Published: (2021-12-01)

The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis
by: Rhiannon Morris, et al.
Published: (2021-12-01)

The Genetic Basis of Primary Myelofibrosis and Its Clinical Relevance
by: Elisa Rumi, et al.
Published: (2020-11-01)

Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in Myelofibrosis
by: Andrew T. Kuykendall, et al.
Published: (2020-08-01)

Risk‐adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosis
by: Naveen Pemmaraju, et al.
Published: (2022-11-01)

Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice
by: Shanti Amé, et al.
Published: (2023-08-01)

Megakaryocytes as the Regulator of the Hematopoietic Vascular Niche
by: Huichun Zhan, et al.
Published: (2022-06-01)

Pycnodysostosis with the focus on clinical and radiographic findings
by: Benjamin Wybrand Barnard, et al.
Published: (2012-06-01)

Retrospective panoramic radiographic analysis for idiopathic osteosclerosis in Indians
by: Srikanth H Srivathsa
Published: (2016-01-01)

Ten years of treatment with ruxolitinib for myelofibrosis: a review of safety
by: Srdan Verstovsek, et al.
Published: (2023-07-01)

Murine Models of Myelofibrosis
by: Sebastien Jacquelin, et al.
Published: (2020-08-01)

Mutational spectrum and prognosis in Chinese patients with prefibrotic primary myelofibrosis
by: Chi‐Keung Cheng, et al.
Published: (2022-02-01)

Organ Stiffness in the Work-Up of Myelofibrosis and Philadelphia-Negative Chronic Myeloproliferative Neoplasms
by: Edoardo Benedetti, et al.
Published: (2020-07-01)

Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing
by: Marta Garrote, et al.
Published: (2023-07-01)

The Use of Allogeneic Hematopoietic Stem Cell Transplantation in Primary Myelofibrosis
by: Heather R. Wolfe, et al.
Published: (2022-04-01)

Targeted sequencing of candidate gene regions for myelofibrosis in dogs
by: Amelia G. Campbell, et al.
Published: (2022-07-01)

Clinical features of children with polycythemia vera, essential thrombocythemia, and primary myelofibrosis in Japan: A retrospective nationwide survey
by: Hisashi Ishida, et al.
Published: (2020-07-01)

Idiopathic Osteosclerosis of the Jaw in a Brazilian Population: a Retrospective Study
by: Elen de Souza Tolentino, et al.
Published: (2014-01-01)

Rare form of intramedullary osteosclerosis in the tibia
by: Luben Stokov, et al.
Published: (2022-12-01)

Rare form of intramedullary osteosclerosis in the tibia
by: Luben Stokov, et al.
Published: (2022-12-01)

Renal osteodystrophy presenting predominantly with osteosclerosis
by: Oriazo Theophilus Akhigbe, et al.
Published: (2015-01-01)

Primary myelofibrosis: current therapeutic options
by: Paula de Melo Campos

JAK Be Nimble: Reviewing the Development of JAK Inhibitors and JAK Inhibitor Combinations for Special Populations of Patients with Myelofibrosis
by: Andrew T. Kuykendall, et al.
Published: (2021-08-01)

Overt-stage primary myelofibrosis after COVID-19 infection: a case report
by: P. Darmada, et al.
Published: (2022-09-01)